Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity
-
- Marta Santos Bravo
- Microbiology Department, Hospital Clinic of Barcelona, Institute of Global Health of Barcelona (ISGlobal), Barcelona, Spain
-
- Carla Berengua
- Microbiology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autonòma de Barcelona, Barcelona, Spain
-
- Pilar Marín
- Microbiology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autonòma de Barcelona, Barcelona, Spain
-
- Montserrat Esteban
- Microbiology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autonòma de Barcelona, Barcelona, Spain
-
- Cristina Rodriguez
- Microbiology Department, Hospital Clinic of Barcelona, Institute of Global Health of Barcelona (ISGlobal), Barcelona, Spain
-
- Margarita del Cuerpo
- Microbiology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autonòma de Barcelona, Barcelona, Spain
-
- Elisenda Miró
- Microbiology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autonòma de Barcelona, Barcelona, Spain
-
- Genoveva Cuesta
- Microbiology Department, Hospital Clinic of Barcelona, Institute of Global Health of Barcelona (ISGlobal), Barcelona, Spain
-
- Mar Mosquera
- Microbiology Department, Hospital Clinic of Barcelona, Institute of Global Health of Barcelona (ISGlobal), Barcelona, Spain
-
- Sonsoles Sánchez-Palomino
- AIDS Research Group, Institut D’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain
-
- Jordi Vila
- Microbiology Department, Hospital Clinic of Barcelona, Institute of Global Health of Barcelona (ISGlobal), Barcelona, Spain
-
- Núria Rabella
- Microbiology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autonòma de Barcelona, Barcelona, Spain
-
- María Ángeles Marcos
- Microbiology Department, Hospital Clinic of Barcelona, Institute of Global Health of Barcelona (ISGlobal), Barcelona, Spain
-
- Angela M. Caliendo
- editor
この論文をさがす
説明
<jats:p> Determining SARS-CoV-2 viral infectivity is crucial for patient clinical assessment and isolation decisions. We assessed subgenomic RNA (sgRNA) as a surrogate marker of SARS-CoV-2 infectivity in SARS-CoV-2-positive reverse transcription PCR (RT-PCR) respiratory samples ( <jats:italic>n</jats:italic> = 105) in comparison with viral culture as the reference standard for virus replication. sgRNA and viral isolation results were concordant in 99/105 cases (94%), indicating highly significant agreement between the two techniques (Cohen’s kappa coefficient 0.88, 95% confidence interval [CI] 0.78 to 0.97, <jats:italic>P</jats:italic> < 0.001). sgRNA RT-PCR showed a sensitivity of 97% and a positive predictive value of 94% to detect replication-competent virus, further supporting sgRNA as a surrogate marker of SARS-CoV-2 infectivity. sgRNA RT-PCR is an accurate, rapid, and affordable technique that can overcome culture and cycle threshold ( <jats:italic> C <jats:sub>T</jats:sub> </jats:italic> ) value limitations and be routinely implemented in hospital laboratories to detect viral infectivity, which is essential for optimizing patient monitoring, the efficacy of treatments/vaccines, and work reincorporation policies, as well as for safely shortening isolation precautions. </jats:p>
収録刊行物
-
- Journal of Clinical Microbiology
-
Journal of Clinical Microbiology 60 (1), e01609-21-, 2022-01-19
American Society for Microbiology